⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3760666 | 0.87 | — | — | |
| SCHEMBL3720088 | 0.87 | — | — | |
| SCHEMBL25227455 | 0.83 | — | — | |
| SCHEMBL28944213 | 0.76 | — | — | |
| SCHEMBL28944212 | 0.76 | — | — | |
| SCHEMBL21435092 | 0.74 | — | — | |
| SCHEMBL12735418 | 0.67 | SMN1; SMN2 (0.33) | — | |
| SCHEMBL2572504 | 0.67 | ALDH1A1 (0.35) | — | |
| SCHEMBL9411062 | 0.66 | — | — | |
| SCHEMBL9411109 | 0.66 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4143179-B1 | AZETIDIN-3-YLMETHANOL DERIVATIVES AS CCR6 RECEPTOR MODULATORS FOR THE TREATMENT OF CANCER | IDORSIA PHARMACEUTICALS LTD (CH) | 2025-10-22 | — | — | EP | disclosed |
| US-20230174514-A1 | AZETIDIN-3-YLMETHANOL DERIVATIVES AS CCR6 RECEPTOR MODULATORS | IDORSIA PHARMACEUTICALS LTD (CH) | 2023-06-08 | — | — | US | disclosed |